Similar articles

• [Specific immunotherapy using cell-mediated immune transfer factor. Preliminary results with semi-purified transfer factor].

  Berthaux P, Moulias R, Goust JM, Reinert P, Fournel JJ. Berthaux P, et al. Ann Med Interne (Paris). 1972 Dec;123(12):1069-72. Ann Med Interne (Paris). 1972. PMID: 4664543 French. No abstract available.
• [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].

  Moulias R, Goust JM, Reinert P, Fournel JJ, Deville-Chabrolle A, Duoung N, Muller-Berat CN, Berthaux P. Moulias R, et al. Nouv Presse Med. 1973 May 19;2(20):1341-4. Nouv Presse Med. 1973. PMID: 4357775 French. No abstract available.
• [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].

  Moulias R, Goust JM, Reinert P, Fournel JJ, Deville-Chabrolle A, Duong N, Muller-Berat CN, Berthaux P. Moulias R, et al. Nouv Presse Med. 1973 May 19;2(20):1341-4. Nouv Presse Med. 1973. PMID: 4351886 French. No abstract available.
• Therapeutic uses of transfer factor.

  Hitzig WH, Grob PJ. Hitzig WH, et al. Prog Clin Immunol. 1974;2:69-100. Prog Clin Immunol. 1974. PMID: 4217910 Review. No abstract available.
• Treatment of infectious and neoplastic diseases with transfer factor.

  Kirkpatrick CH, Gallin JI. Kirkpatrick CH, et al. Oncology. 1974;29(1):46-73. doi: 10.1159/000224888. Oncology. 1974. PMID: 4600778 Review. No abstract available.